The nation of Zimbabwe has declined a substantial American health deal worth 367 million US dollars (£272m) over five years over Washington's request for sensitive information.
The decision came to light following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government representative later clarified that the US was demanding access to genetic material for scientific study and profit while was not willing to guarantee the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued negotiations to find a deal suitable to all parties so the nation's critical HIV programme can continue.
Wider Background
This rejection comes after a comparable case in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were filed about the security of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral deals to boost openness and accountability.
Based on reports, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to provide its biological resources and data over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our citizens if a future pandemic arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks already established via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its samples, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how subsequent co-operation might be structured in a manner that respects the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that negotiations must proceed considering much of the nation's HIV programmes were funded by external financing.
"In cases where specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group commented.
The halted deal underscores the complex tensions between receiving crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.